From the Guidelines
Meclizine is used as an antivertigo agent.
Uses of Meclizine
- Meclizine is classified under the ATC code R06AD01, which indicates its use as an antihistamine for systemic use, specifically for the treatment of vertigo and other balance disorders 1.
- The medication is considered sometimes appropriate for use in palliative care, particularly for managing symptoms such as vertigo 1.
- In the context of advanced dementia care, Meclizine may be used to manage vertigo and other symptoms that affect the patient's quality of life 1.
- However, the use of Meclizine should be carefully evaluated in patients with limited life expectancy, as its benefits and risks need to be weighed against the patient's goals of care and quality of life 1.
From the FDA Drug Label
MECLIZINE HYDROCHLORIDE tablets, for oral use Initial U. S. Approval: 1957 INDICATIONS AND USAGE Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults (1).
Meclizine is used for the treatment of vertigo associated with diseases affecting the vestibular system in adults 2.
From the Research
Meclizine Uses
- Meclizine is used for the treatment of motion sickness and vertigo 3, 4, 5
- It is an antihistamine that has been widely used for prophylactic treatment and management of motion sickness 4
- Meclizine is also used to manage nausea and vomiting with few adverse effects 6
- Additionally, meclizine has shown promise as an anti-eczema treatment, with potential activity against eczema 7
Meclizine Formulations
- Meclizine is available in various formulations, including oral tablets, suspension, and orodissolvable/dispersible tablets 4, 6
- A new dual function orodissolvable/dispersible meclizine HCL tablet has been developed to challenge patient inconvenience, with rapid and prolonged efficacy 6
- Meclizine ointment has also been formulated and studied for its anti-eczema activity, with promising results 7